Neuberg Diagnostics, a newly formed international alliance of five laboratories from Bangalore, India; Ahmedabad, India; Chennai, India; South Africa and Dubai is further expanding its global footprint into Africa and Western Asia regions.
Chennai headquartered Neuberg will be opening new labs in Kenya and Tanzania this year with Nigeria and Ghana in the pipeline. Through an acquisition of Global Clinical & Viral Lab, a center for virology in Durham, South Africa, Neuberg will focus on addressing tuberculosis and HIV testing in the African market.
Neuberg Diagnsotics Chairman GSK Velu had earlier this year talked about investing INR 300 crore for further expansion and growth. The company will also be expanding its portfolio into other personalized medicine initiatives.